Portfolio company
Oxford Brain Diagnostics
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops software that analyses MRI scans to measure brain health and support dementia diagnosis for clinicians and pharmaceutical firms.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Quantified Imaging
This company develops radiological imaging software for measuring brain blood flow to help clinicians and pharmaceutical firms diagnose and monitor dementia.
Brainreader
This company develops medical software that provides automated volumetric analysis of brain MRI scans for radiologists and neurologists to aid disease diagnosis.
BrainQuant
This company develops artificial intelligence software that analyses magnetic resonance imaging sequences to detect neurodegenerative diseases for medical institutions and clinical researchers.
DICEtech
This company develops medical imaging software that analyses magnetic resonance imaging data to support diagnostic decision-making for clinicians in oncology and neurology.
BrainCheck
This company develops digital cognitive assessment and care planning software for healthcare providers, health systems, and dementia care management organisations.
mediaire
This company develops artificial intelligence software for MRI scan analysis to assist radiologists in hospitals and clinics with diagnostic reporting.
Combinostics
This company develops AI software for quantifying brain images and patient data to support clinicians in diagnosing and managing neurological disorders.
CFDX
CFDX develops artificial intelligence technology to detect dementia earlier than traditional methods for healthcare providers and clinical research organisations.
